ea0090rc9.2 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023
Tschaidse Lea
, Wimmer Sophie
, Auer Matthias
, Lottspeich Christian
, F. Nowotny Hanna
, Dubinski Ilja
, Schmidt Heinrich
, Quinkler Marcus
, Reisch Nicole
Background: Patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) require lifelong glucocorticoid replacement therapy, including stress dose adjustment to prevent life-threatening adrenal crises (AC). Previous studies indicate a high incidence of inadequate stress dose adjustment and AC in patients with CAH. The aim of this study was to prospectively assess AC incidence, frequency and details of stress dose adjustment as well as knowledge of the d...